InfuSystem Holdings, Inc. (INFU) P/E Ratio History
Historical price-to-earnings valuation from 2007 to 2026
Loading P/E history...
INFU Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, InfuSystem Holdings, Inc. (INFU) trades at a price-to-earnings ratio of 28.9x, with a stock price of $8.96 and trailing twelve-month earnings per share of $0.38.
The current P/E is 90% below its 5-year average of 295.2x. Over the past five years, INFU's P/E has ranged from a low of 23.5x to a high of 2597.0x, placing the current valuation at the 30th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, INFU trades at a 29% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, INFU trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our INFU DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
INFU P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 27.5 | -Best | +53% | |
| $124M | 24.6 | -Best | +125%Best | |
| $2B | 978.1 | -Best | -84% | |
| $548M | 11.5Lowest | -Best | +14% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
INFU Historical P/E Data (2007–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $9.23 | $0.38 | 24.5x | -84% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $8.97 | $0.32 | 28.3x | -81% |
| FY2025 Q3 | $10.36 | $0.26 | 39.4x | -74% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $6.24 | $0.23 | 26.8x | -82% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $5.38 | $0.14 | 37.6x | -75% |
| FY2024 Q4 | $8.45 | $0.10 | 82.1x | -46% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $6.70 | $0.06 | 105.8x | -31% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $6.83 | $0.01 | 513.5x | +237% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $8.57 | $0.00 | 2597.0x | +1604% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $10.54 | $0.03 | 316.5x | +108% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $9.64 | $0.04 | 241.0x | +58% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $9.63 | $0.03 | 321.0x | +111% |
Average P/E for displayed period: 152.4x
See INFU's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INFU Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare INFU vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonINFU — Frequently Asked Questions
Quick answers to the most common questions about buying INFU stock.
Is INFU stock overvalued or undervalued?
INFU trades at 28.9x P/E, below its 5-year average of 295.2x. At the 30th percentile of historical range, the stock is priced at a discount to its own history.
How does INFU's valuation compare to peers?
InfuSystem Holdings, Inc. P/E of 28.9x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is INFU's PEG ratio?
INFU PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2007-2026.